To evaluate the efficiency of three artificial intelligence (AI) chatbots (ChatGPT-3.5 (OpenAI, San Francisco, California, United States), Bing Copilot (Microsoft Corporation, Redmond, Washington, United States), Google Gemini (Google LLC, Mountain View, California, United States)) in assisting the ophthalmologist in the diagnostic approach and management of challenging ophthalmic cases and compare their performance with that of a practicing human ophthalmic specialist. The secondary aim was to assess the short- and medium-term consistency of ChatGPT's responses.
No takes yet. Share an insight, caveat, or question.
Mandalos et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: